The International Society for Biological Therapy of Cancer (iSBTc) 22nd Annual MeetingNovember 2-4, 2007Seaport World Trade Center in Boston, MassachusettsProgram Organizers George Coukos, MD, PhD - University of Pennsylvania Medical CenterF. Stephen Hodi, MD - Dana-Farber Cancer InstituteJames C. Yang, MD - National Cancer InstituteProgram SummaryThe Annual Meeting featured an interactive environment that facilitated productive discourse among clinicians, researchers, students, post-doctoral fellows, and allied health professionals from the US, Europe, Asia and beyond. The meeting included over 50 high-quality scientific lectures and 135 posters related to angiogenesis and vascular therapies, cellular therapies, characterizing the host response to cancer, combination therapy for cancer, cytokines, immunoregulation and mediated, tolerance, inflammation and innate immunity, new agents, tumor microenvironment, tumor recognition and immune evasion, and vaccines and dendritic cells.Intended AudienceThe target audience for these programs incorporates basic and clinical investigators from academic, regulatory and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows and allied health professionals.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com